We build and invest
We build our portfolio from the bottom up investing in companies directly involved with cannabis or ancillary in the industry. Our clients own the actual holdings in their own separate account.
Companies we seek are publicly traded on exchanges such as the (CSE) Canadian Stock Exchange, (NYSE) New York Stock Exchange, or NASDAQ. Our portfolio seeks diversification by including various businesses in the cannabis industry. These may include grow, distribution, packaging, real estate, retail, and pharmaceutical companies. Our portfolio is long term focused and designed to build lasting shareholder value.
Management and established talent is primary to investing in any cannabis company
We see our role as partnering with great businesses and experienced management that demonstrate and execute a strategy that is broadly focused on domestic and global reach. Our focus on management, governance, and board direction are a priority. We are long term owners and allied with leadership driven to perform for shareholders, respect employees, and have the highest ethical standards.
Cannabis by the numbers
Countries Medical Legal
u.s. recreational or medical
expected sales 2019
Legalization through the States is the best way forward
— Jaime McMillan - Founder Cannabis Capital Growth
Foundation of Investing
Cannabis companies are business entities, both privately and publicly owned, we focus on publicly companies to invest in for our clients. We review hundreds of opportunities across the eco system of cannabis.
Building a portfolio of leading cannabis companies is a process of analysis and screening for the best investments. We own 13 to 17 companies small, medium, and large capitalization companies in our portfolio.
Diversification among cannabis companies is critical to success. From growers, extraction, pharma, retail, medical, real estate, edibles, to beverages there’s much growth ahead and much opportunity.
We align ourselves with proven management and industry talents coming into the cannabis industry. The next wave of leaders are transferring form alcohol, tobacco, consumer goods, technology, and marketing.